edesabiotech.com - Rasio nilai perusahaan marang pendapatan EDSA

Logo perusahaan publik Edesa Biotech Inc (EDSA)

A stable staff of immunologists provides Edesa Biotech, Inc. (EDSA) with a reliable scientific foundation. The EV/Sales multiple trajectory is currently moving sideways, with the current figure standing at 0.00. Asset value growth depends on the success of inflammation therapies and patent protection. The primary catalyst will be the progress of the EB05 drug and potential interest from the largest pharmaceutical behemoths.

Edesa Biotech, Inc. (EDSA): Rasio nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.11.2026

Rincian metrik keuangan lan pasar Edesa (EDSA)

Pambiji fundamental perusahaan:Edesa Biotech, Inc. - EDSA
Produk seri Edesa Biotech Inc

To assess the credit quality of Edesa Biotech, Inc. (EDSA), the analyst utilizes the EV/Sales multiple, which determines the enterprise value including net debt per unit of sales. By analyzing the change in the company's value relative to revenue, the investor can gauge the asset's degree of overheating, which is critical for the biotechnology sector, where patent protection for drugs competes with aggressive pressure from international immunological analogs for investment capital.

Analisis pesaing Edesa Biotech, Inc.

ARGX - Multiplikator EV/Sales|BNTX: Multiplikator EV/Sales|ABVX (Abivax SA) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan ADMA Corp|Multiplikator nilai perusahaan marang pendapatan Protagonist Therapeutics PTGX|Nilai perusahaan marang pendapatan IMVT (Immunovant Therapeutics)|Rasio total nilai perusahaan marang pendapatan kiniksa.com|Rasio nilai perusahaan marang pendapatan Grifols Biemat GRFS|Koefisien nilai perusahaan marang pendapatan ADPT (Adaptive Biotechnologies Corporation)|celldex.com - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan Aurinia Pharma AUPH|biocryst.com (BCRX) - Rasio nilai perusahaan marang pendapatan|Vera Therapeutics, Inc. - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Dianthus Therapeutics Inc|Pharvaris NV (PHVS) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales ABCL|Tourmaline Corp - Rasio nilai perusahaan marang pendapatan|Multiplikator EV/Sales PGEN (precigen.com)|Rasio nilai perusahaan marang dodolan pharming.com|NKTR - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Upstream Bio Corp|ZBIO: Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Immunome, Inc.|Nilai perusahaan marang pendapatan GOSS|KALV: Nilai bisnis marang pendapatan|Multiplikator EV/Sales SEPN|Nilai perusahaan marang pendapatan Pieris Pharmaceuticals, Inc. PVLA|Multiplikator EV/Sales SVRA (Savara Inc)|Multiplikator EV/Sales Rigel Pharmaceuticals RIGL|AnaptysBio Inc. - Multiplikator EV/Sales|Astria Therapeutics - Koefisien nilai perusahaan marang pendapatan|ENGN: Multiplikator EV/Sales|RAPT - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan JBIO|Aclaris (ACRS) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales KYTX|Nilai perusahaan marang pendapatan Tiziana Life Sciences TLSA|Multiplikator EV/Sales CABA (cabalettabio.com)|Koefisien nilai perusahaan marang pendapatan VTYX (Ventyx Bio)|Theratechnologies, Inc - Multiplikator EV/Sales|AVTX (Avalo Therapeutics Inc.) - Rasio nilai perusahaan marang pendapatan|eledon.com (ELDN) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan AGEN|CLYM (climbbio.com) - Multiplikator EV/Sales|Multiplikator EV/Sales zurabio.com|Rasio nilai perusahaan marang pendapatan aTyr (ATYR)|ADAG - Multiplikator nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan ImageneBio Inc IMA|Multiplikator EV/Sales Shattuck Labs, Inc. STTK|EQ - Rasio nilai perusahaan marang pendapatan|connectbiopharm.com (CNTB) - Nilai perusahaan marang pendapatan|IMUX (Immunic) - Nilai perusahaan marang pendapatan|Atara Biotherapeutics, Inc. - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan InflaRx|Nilai perusahaan marang pendapatan x4pharma.com (XFOR)|Multiplikator EV/Sales ACET|Nilai perusahaan marang pendapatan Celularity Corp CELU|INmune Bio Inc - Nilai perusahaan marang pendapatan|BRNS (Barinthus Bio) - Nilai perusahaan marang volume dodolan|KZR - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan sabbiotherapeutics.com SABS|Akari Therapeutics PLC (AKTX) - Rasio nilai perusahaan marang pendapatan|ENLV - Rasio total nilai perusahaan marang pendapatan|QTTB (Q32 Bio) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan GeoVax Labs Inc GOVX|Multiplikator EV/Sales IBIO|Nilai perusahaan marang pendapatan Carisma Tx CARM|Rasio nilai perusahaan marang pendapatan XTL Biopharmaceuticals Ltd XTLB|Multiplikator EV/Sales Bolt Biotherapeutics BOLT|HCW Biologics - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan aptevotherapeutics.com|AIM (AIM ImmunoTech, Inc.) - Nilai perusahaan marang pendapatan|Aditxt Corp - Nilai bisnis marang pendapatan|GRI (GRI Bio Inc) - Multiplikator EV/Sales|Multiplikator EV/Sales XORTX Therapeutics Inc|Rasio nilai perusahaan marang pendapatan Vyome Therapeutics (HIND)|REVB - Multiplikator nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Indaptus Therapeutics, Inc. INDP|Multiplikator EV/Sales scinai.com SCNI|CalciMedica Inc - Multiplikator EV/Sales|AFMD - Multiplikator EV/Sales|ALLK: Multiplikator EV/Sales|Nilai perusahaan marang volume dodolan HOOK (HOOKIPA Pharma, Inc.)|IGMS (IGM Biosciences) - Multiplikator EV/Sales|ITOS: Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan OCEA (Ocean Biomedical)|TCBP: Nilai perusahaan marang volume dodolan|Rasio nilai perusahaan marang pendapatan Third Harmonic Bio Inc THRD